Antioxidant therapy for severe sepsis: Promise and perspective

Critical Care Medicine

Volumn 31, Issue 11, 2003, Pages 2697-2698

  Pinsky, Michael R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Sepsis

Indexed keywords

ACETYLCYSTEINE; ACTIVATED PROTEIN C; ANTIOXIDANT; IMMUNOMODULATING AGENT; SELENIUM;

CLINICAL TRIAL; DRUG MECHANISM; EDITORIAL; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFUSION; INTENSIVE CARE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ACETYLCYSTEINE; ANTIOXIDANTS; HUMANS; NF-KAPPA B; REPRODUCIBILITY OF RESULTS; SEPSIS;

EID: 0344011022     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000089942.54922.FF     Document Type: Editorial

References (26)

1. Adrie C, Pinsky MR: The inflammatory balance in human sepsis. Intensive Care Med 2000; 26:364-375
2. Goldie AS, Fearon KC, Ross JA, et al: Natural cytokine antagonists and endogenous anti-endotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. J Am Med Assoc 1995; 274:172-217
3. Wang SD, Huang KJ, Lin YS, et al: Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 1994; 152:5014-5021
4. Adrie C, Bachelet M, Vayssier-Taussat M, et al: Mitochondrial membrane potential and apoptosis in peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med 2001; 164:389-395
5. Adib-Conquy M, Adrie C, Moine P, et al: NF-κB expression in mononuclear cells of septic patients resembles that observed in LPS-tolerance. Am J Respir Crit Care Med 2000; 162:1877-1883
6. Rosenbloom AJ, Pinsky MR, Napolitano C, et al: Suppression of cytokine mediated β2-integrin activation on circulating neutrophils in critically ill patients. J Leukoc Biol 1999; 66:83-89
7. Wong HR, Finder JD, Wasserloos K, et al: Transcriptional regulation of inducible nitric oxide synthase by interleukin-1β in cultured rat pulmonary artery smooth muscle cells. Am J Physiol 1996; 271:L166-L171
8. Heck DA, Bylund DB: Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 1997; 282: 1219-1227
9. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 2001; 345:1359-1367
10. Hinshaw LB: Sepsis/septic shock: Participation of the microcirculation: An abbreviated review. Crit Care Med 1996; 24:1072-1078
11. Rosenbloom A, Pinsky MR, Bryant JL, et al: Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS: Correlation with serum interleukin-6 levels and organ dysfunction. J Am Med Assoc 1995; 274:58-65
12. Noursadeghi M, Bickerstaff MC, Gallimore JR, et al: Role of serum amyloid P component in bacterial infection: Protection of the host or protection of the pathogen. Proc Natl Acad Sci USA 2000; 97:14584-14589
13. Simonson SG, Welty-Wolf K, Huang YUT, et al: Altered mitochondrial redox responses in Gram-negative septic shock. Circ Shock 1994; 43:34-43
14. Fink M: Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 1997; 110:87-95
15. Abraham E: Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 1999; 25:556-566
16. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
17. Szabo CS, Cuzzocrea B, Zingarelli B, et al: Endothelial dysfunction in a rat model of endotoxic shock: Importance of the activation of the poly(ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100:723-735
18. Cowley HC, Bacon PJ, Goode HF, et al: Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit Care Med 1996; 24:1179-1183
19. Goode HF, Cowley HC, Walker BE, et al: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23:646-651
20. Goode HF, Webster NR: Free radicals and antioxidants in sepsis. Crit Care Med 1993; 21:1770-1775
21. Angstwurm MW, Schottdorf J, Schopohl J, et al: Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27:1807-1813
22. Pearce LL, Gandley RE, Han W, et al: A role for metallothionein in physiological nitric oxide signaling. Proc Natl Acad Sci U S A 2000; 97:477-482
23. Paterson RL, Galley HF, Webster NR: The effect of N-acetylcysteine on nuclear factor-KB activation, interleukin-6, interleukin-8, and intracellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31:2574-2578
24. Liu SF, Ye X, Malik AB: In vivo inhibition of nuclear factor-KB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997; 159:3976-3983
25. Moncada S, Palmer RM, Higgs EA, et al: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-143
26. Hays MA, Timmins AC, Yau EHS, et al: Elevation of systemic oxygen delivery in critically ill patients. N Engl J Med 1994; 330: 1717-1722